Stark / Raving Health, a global patient recruitment agency, announced today the promotion of Laura Wayne to the position of Account Manager, Global Patient Recruitment. Laura’s exceptional dedication, operational mindset, and expertise in project management have made her an invaluable asset to the agency.

Laura WayneIn her new role, Laura will take on a broader set of responsibilities, including overseeing client accounts, nurturing client relationships, and identifying opportunities for business growth.

Stark / Raving Health’s Senior Director of Business Development, Gabrielle DeBoer commented, “Laura has quickly demonstrated her exceptional skills in managing complex projects, exceeding client expectations, and building relationships with Sponsors, CROs, and clinical teams. Her ability to maintain a focus on client relationships, coupled with her strategic thinking and problem-solving abilities, will play a significant role in the continued growth and success of our agency.”

“Laura’s promotion is a testament to her hard work and passion for advancing our agency-wide commitment to providing our clients with the highest level of service, flexibility, and transparency,” said Matthew Stumm, President, and Founder of Stark / Raving Health. “We eagerly anticipate the positive impact she will undoubtedly make on our clients and the operations of our agency.”

In her new role as Account Manager, Laura will report directly to Gabrielle DeBoer.

For more information about how Stark / Raving Health develops and executes patient recruitment campaigns that accelerate clinical trial enrollment, please visit

About Stark / Raving Health
Stark / Raving Health is an independently owned patient recruitment agency that accelerates global clinical trial enrollment using engaging study toolkits, patient-centric digital experiences, and targeted outreach campaigns. Our approach is built on 20+ years of successfully delivering hundreds of patient recruitment campaigns across a range of therapeutic areas in more than 40 countries and over 70 languages. Our ability to scale our streamlined approach and successfully deliver patients has made us a go-to resource for the world’s leading biotechs, pharmaceutical companies, and CROs.

To learn more, visit